Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
239.67
-0.50 (-0.21%)
Nov 22, 2024, 4:00 PM EST - Market closed
Labcorp Holdings Operating Income by Segment
History
| Date | Diagnostics | Drug Development | General Corporate Expenses |
|---|---|---|---|
| Sep 30, 2024 | 1.60B | 437.20M | -269.00M |
| Jun 30, 2024 | 1.60B | 425.30M | -273.20M |
| Mar 31, 2024 | 1.57B | 422.50M | -382.10M |
| Dec 31, 2023 | 1.59B | 446.50M | -389.00M |
| Sep 30, 2023 | 1.62B | 546.00M | -406.80M |
| Jun 30, 2023 | 1.68B | 647.70M | -396.80M |
| Mar 31, 2023 | 1.78B | 756.40M | -291.70M |
| Dec 31, 2022 | 2.03B | 801.10M | -277.50M |
| Sep 30, 2022 | 2.41B | 798.30M | -276.80M |
| Jun 30, 2022 | 2.75B | 813.70M | -309.30M |
| Mar 31, 2022 | 2.90B | 821.50M | -280.90M |
| Dec 31, 2021 | 3.21B | 887.00M | -267.00M |
| Sep 30, 2021 | 3.66B | 929.70M | -235.40M |
| Jun 30, 2021 | 3.89B | 913.30M | -199.30M |
| Mar 31, 2021 | 3.54B | 804.90M | -195.70M |
| Dec 31, 2020 | 2.80B | 721.60M | -191.00M |
| Sep 30, 2020 | 1.84B | 656.40M | -176.00M |
| Jun 30, 2020 | 1.14B | 621.70M | -159.00M |
| Mar 31, 2020 | 1.17B | 650.70M | -158.40M |
| Dec 31, 2019 | 1.23B | 637.90M | -156.30M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.